News AbbVie Files for Expanded Approval of Skyrizi in Ulcerative Colitis by Warren Seah August 28, 2023 by Warren Seah August 28, 2023 AbbVie, the biopharmaceutical company based in North Chicago, Illinois, has submitted applications for expanded approval of… Read more